×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 5, Track B: New Era for Signal Detection
Session Chair(s)
Gislaine Villarta Capeleti Dib, PharmD
Patient Safety Manager
PGA Farma, Brazil
Yoon Jeon (Jamey) Kim, MSc, RPh
Cluster Pharmacovigilance Lead for Latin America
MSD, Panama
In this session, we will Navigate the new era of pharmacovigilance, exploring innovations in signal detection across various sources and products. We will discuss the impact of innovative signal detection approaches on patient safety.
Learning Objective : - Gain insights on regulatory considerations, methods and types of initiatives in the LATAM Region
- Examine the integration of multi-modal data sources and products for comprehensive signal detection and validation
- Recognize common challenges/traps and ways out in the new era of pharmacovigilance
- Evaluate case studies and success stories showcasing the impact of innovative signal detection approaches on patient safety
Speaker(s)
Handling Multiple Data Sources and Large Databases in Signal Evaluation
Mariângela Luchezi, RPh
Eli Lilly and Company, Brazil
Sr Associate - Clinical Surveillance
Signal Detection in High Social Media Exposure Scenario
Stefania de Azevedo Fraletti
Novo Nordisk, Brazil
Quality Assurance Manager and Interim Director of Quality Assurance, Pharmacovig
Case Study of Automation in Signal Detection Implemented by a Brazilian Public Laboratory
Marcelo Eiji Koike, PharmD, MBA
Instituto Butantan, Brazil
Pharmacovigilance Specialist
Have an account?